SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-09-116019
Filing Date
2009-05-21
Accepted
2009-05-20 21:42:46
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 ds3.htm S-3 227305
2 2004 STOCK INCENTIVE PLAN dex43.htm EX-4.3 106531
3 FORM OF WARRANT dex45.htm EX-4.5 33956
4 OPINION OF LATHAM & WATKINS LLP dex51.htm EX-5.1 11840
5 CONSENT OF BDO SEIDMAN, LLP dex231.htm EX-23.1 1848
6 CONSENT OF GRANT THORNTON LLP dex232.htm EX-23.2 1490
8 GRAPHIC g93028image001.jpg GRAPHIC 3187
9 GRAPHIC g93028image002.jpg GRAPHIC 1793
10 filename10.htm COVER 8165
  Complete submission text file 0001193125-09-116019.txt   399732
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-159374 | Film No.: 09843946
SIC: 2834 Pharmaceutical Preparations